Society guideline links: Pulmonary hypertension in adults

Introduction — This topic includes links to society and government-sponsored guidelines from selected countries and regions around the world. We will update these links periodically; newer versions of some guidelines may be available on each society's website. Some societies may require users to log in to access their guidelines.

The recommendations in the following guidelines may vary from those that appear in UpToDate topic reviews. Readers who are looking for UpToDate topic reviews should use the UpToDate search box to find the relevant content.

Links to related guidelines are provided separately:

●(See "Society guideline links: Myocarditis".)

●(See "Society guideline links: Pulmonary hypertension in children".)

International

●International Consortium for Genetic Studies in PAH (PAH-ICON): A consensus statement on genetic counselling and testing in pulmonary arterial hypertension (2023)

●International Society for Heart and Lung Transplantation (ISHLT): Consensus statement for perioperative management of patients with pulmonary hypertension and right heart failure undergoing surgery (2022)

●The Fleischner Society: Position paper on imaging of pulmonary hypertension in adults (2021)

●Sixth World Symposium on Pulmonary Hypertension (WSPH): Haemodynamic definitions and updated clinical classification of pulmonary hypertension (2019)

●International Liver Transplantation Society (ILTS): Practice guidelines – Diagnosis and management of hepatopulmonary syndrome and portopulmonary hypertension (2016)

Canada

●Canadian Cardiovascular Society (CCS)/Canadian Thoracic Society (CTS): Position statement on pulmonary hypertension (2020)

●CTS: Clinical practice guideline for diagnosis of chronic thromboembolic pulmonary hypertension, update (2019)

United States

●American College of Radiology (ACR): ACR Appropriateness Criteria on suspected pulmonary hypertension (2022)

●American College of Chest Physicians (CHEST): Guideline and expert panel report on antithrombotic therapy for VTE disease, second update (2021)

●CHEST: Guideline and expert panel report on therapy for pulmonary arterial hypertension in adults, update (2019)

●American Society of Hematology (ASH): Guidelines for sickle cell disease – Cardiopulmonary and kidney disease (2019)

●American Thoracic Society (ATS): Clinical practice guideline for the diagnosis, risk stratification, and management of pulmonary hypertension of sickle cell disease (2014)

●ATS: Statement on pulmonary hypertension phenotypes (2014)

●American Heart Association (AHA): Scientific statement for the management of massive and submassive pulmonary embolism, iliofemoral deep vein thrombosis, and chronic thromboembolic pulmonary hypertension (2011)

●American College of Cardiology Foundation (ACCF)/AHA: Expert consensus on pulmonary hypertension (2009)

Europe

●European Society of Cardiology (ESC)/European Respiratory Society (ERS): Guidelines on diagnosis and treatment of pulmonary hypertension (2022)

Japan

●[In Japanese] Japanese Circulation Society (JCS)/Japanese Pulmonary Circulation and Pulmonary Hypertension Society (JPCPHS): Guidelines for the treatment of pulmonary hypertension, update (2021)